REQUESTS TO SPEAK IN THE

OPEN PUBLIC HEARING SESSIONS

AT BPAC

March 17 & 18, 2005

 

First OPH Session

March 17, 2005, 11:00 a.m. (Albumin)

 

  1. Dr. Samuel O. Coker of Pall Medical  on Pall SMART filter technology to remove different strains of infectious prions, including vCJD prions.
  2. Dr. Celso Bianco, ABC Executive Vice President,  on  West Nile virus testing  
  3. Mr. Jan M. Bult (President of  Plasma Protein Therapeutics Association, PPTA  on Albumin
  4. Dr. Gary R. Haynes, Medical University of South Carolina on Albumin

5.       Joseph Latino, Director of Research, LipidViro Tech, re: "Inactivation of Prion in Biological Fluids". 

Second OPH Session

March 17, 2005, 3:50 p.m. (Plasma Products)

  1. G. Michael Fitzpatrick, PhD, ABC Chief Policy and Chief Operating Officer, on  Rapid freezing of plasma for transfusion
  2. Kay Gregory, Director Regulatory Affairs AABB on the issue of Plasma Products for Transfusion
  3.  Mr. Joshua Penrod (Manager, Regulatory Policy of PPTA): Review of Standards for Plasma Products for Transfusion

 

 

Third OPH Session

March 18, 2005, 9:30 a.m. (Abbreviated Donor Questionnaire)

 

  1. Ms. Mary Gustafson (Senior Director, Global Regulatory Policy of PPTA):  AABB Abbreviated Questionnaire

Written Comments

  1. Gary Haynes MD, PH.D. on albumin through Keith Berman

2.  Terry S. Singletary